ACE — Ascelia Pharma AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK459.60m
- SEK438.81m
2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 225 | 185 | 262 | 150 | 21.9 |
Net Total Receivables | 1.67 | 2.6 | 5.56 | 4.53 | 2.46 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 230 | 196 | 275 | 161 | 28.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.275 | 1.99 | 1.82 | 0.625 | 1.06 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 287 | 255 | 333 | 219 | 87.1 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 11.2 | 18.4 | 25.1 | 37.5 | 12.6 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.3 | 19.3 | 25.7 | 37.7 | 12.7 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 276 | 236 | 308 | 181 | 74.3 |
Total Liabilities & Shareholders' Equity | 287 | 255 | 333 | 219 | 87.1 |
Total Common Shares Outstanding |